|
TXNDC12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03059791203941E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.605205519847E-12 |
| Normal-vs-Stage2 |
4.010400E-04 |
| Normal-vs-Stage3 |
8.29070145869082E-11 |
| Normal-vs-Stage4 |
2.55109999791614E-09 |
| Stage1-vs-Stage2 |
3.972000E-01 |
| Stage1-vs-Stage3 |
4.056200E-01 |
| Stage1-vs-Stage4 |
1.604180E-01 |
| Stage2-vs-Stage3 |
2.109000E-01 |
| Stage2-vs-Stage4 |
1.258840E-01 |
| Stage3-vs-Stage4 |
5.579800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67355018731996E-12 |
| Normal-vs-AfricanAmerican |
7.047900E-04 |
| Normal-vs-Asian |
5.900500E-02 |
| Caucasian-vs-AfricanAmerican |
1.658320E-02 |
| Caucasian-vs-Asian |
7.773400E-01 |
| AfricanAmerican-vs-Asian |
1.820570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.19764223380525E-12 |
| Normal-vs-Female |
1.80677695027498E-12 |
| Male-vs-Female |
6.167200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.955000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.25109922421984E-11 |
| Normal-vs-Age(61-80Yrs) |
2.89746004966673E-12 |
| Normal-vs-Age(81-100Yrs) |
4.358400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.128200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.342600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.942800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.571200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.257200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.288800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.821500E-04 |
| Normal-vs-Grade 2 |
1.64512847788956E-12 |
| Normal-vs-Grade 3 |
3.74489994570126E-09 |
| Normal-vs-Grade 4 |
2.2077000227938E-09 |
| Grade 1-vs-Grade 2 |
6.245200E-01 |
| Grade 1-vs-Grade 3 |
6.913800E-01 |
| Grade 1-vs-Grade 4 |
4.957000E-01 |
| Grade 2-vs-Grade 3 |
1.195830E-02 |
| Grade 2-vs-Grade 4 |
5.400000E-01 |
| Grade 3-vs-Grade 4 |
1.810240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.77569070558548E-12 |
| Normal-vs-ccB subtype |
5.0368997861483E-10 |
| ccA subtype-vs-ccB subtype |
9.864200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.2323700927559E-12 |
| Normal-vs-N1 |
8.418100E-04 |
| N0-vs-N1 |
1.037810E-01 |
|
|
